SEC Form 4 · accession 0000939767-16-000129
EXELIXIS, INC. · EXEL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stelios Papadopoulos
Director
Period of report
Jan 4, 2016
Accepted (ET)
Jan 5, 2016 · 7:55 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000939767
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Jan 4, 2016 | A | 15,071 | $0.00 | A | 1,228,471 | D | |
| Common StockF4 | holding | — | — | — | 10,000 | I | By Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock.
- F2The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2014 Equity Incentive Plan. The restricted stock units will vest as to 1/4th of the aggregate number of restricted stock units granted on each of April 1, 2016, July 1, 2016, September 30, 2016 and December 30, 2016.
- F3Includes 15,071 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
- F4Shares are held by Fondation Sante, of which the Reporting Person is co-trustee.
Remarks
EXHIBIT LIST: Exhibit 24 - Power of Attorney